Neurocrine Biosciences (NBIX) announced an update on their ongoing clinical study.
Johnson & Johnson announced positive topline results from its Phase 2 randomized placebo-controlled JASMINE study. The drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback